Are peptides actually safe, or are concerns being driven by misunderstanding and incomplete data?In this episode of the HRT University podcast, Nico Misleh explores one of the most common concerns in hormone therapy today: peptide safety. With changing regulations and limited human data on some newer peptides, many providers and patients are asking important questions about risk, safety, and long-term use.Nico walks through the historical lessons from hormone therapy that still impact medicine today, including the long-standing myths surrounding testosterone and prostate cancer, as well as the widespread fear that followed the Women’s Health Initiative (WHI) study. These examples highlight why understanding mechanisms matters more than blindly accepting conclusions from flawed or incomplete research.If you work in hormone therapy or are considering peptide-based treatments, this episode will help you better understand how to evaluate safety and think critically about emerging therapies.In This Episode, You'll Learn:Why many peptides have long-standing safety recordsHow flawed studies shaped hormone therapy historyWhat the testosterone and prostate cancer myth teaches usWhy the WHI study changed hormone therapy for decadesThe importance of understanding mechanisms of actionHow clinicians can evaluate new therapies responsiblyFor practitioners who want to confidently grow their practice with guidance in TRT, HRT, and business strategy, find us below:- Nico's Daily Newsletter: ⁠⁠https://nicomislenp.kit.com/8050eeea5f⁠⁠(yes, it's daily... and yes, people stay subscribed)- Join HRT University:https://bit.ly/4twBb0D- Join the HRT University Facebook Group: ⁠⁠https://www.facebook.com/groups/1179376819949373/?ref=share&_rdr